366
Views
12
CrossRef citations to date
0
Altmetric
Perspective

How do nocebo effects in placebo groups of randomized controlled trials provide a possible explicative framework for the COVID-19 pandemic?

ORCID Icon, ORCID Icon & ORCID Icon
Pages 439-444 | Received 25 Jan 2021, Accepted 05 Mar 2021, Published online: 12 Mar 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Martina Amanzio, Giuseppina Elena Cipriani & Dimos D. Mitsikostas. (2022) The nocebo phenomenon in the COVID-19 pandemic: a nocebodemic effect. Expert Review of Clinical Pharmacology 15:12, pages 1377-1382.
Read now

Articles from other publishers (11)

Laura Melgarejo, Edoardo Caronna, Joana Rosell‐Mirmi, Iker Elosua‐Bayés, Alicia Alpuente, Marta Torres‐Ferrus, Víctor J. Gallardo & Patricia Pozo‐Rosich. (2023) Migraine worsening after COVID ‐19 and COVID ‐19 vaccination: Are we facing a nocebo effect? . European Journal of Neurology 30:12, pages 3877-3885.
Crossref
Felix Werner, Nikoletta Zeschick, Thomas Kühlein, Philipp Steininger, Klaus Überla, Isabelle Kaiser, Maria Sebastião, Susann Hueber & Lisette Warkentin. (2023) Patient-reported reactogenicity and safety of COVID-19 vaccinations vs. comparator vaccinations: a comparative observational cohort study. BMC Medicine 21:1.
Crossref
Kimberly N. Garces, Alexandra N. Cocores, Peter J. Goadsby & Teshamae S. Monteith. (2022) Headache After Vaccination: An Update on Recent Clinical Trials and Real-World Reporting. Current Pain and Headache Reports 26:12, pages 895-918.
Crossref
Charles Khouri, Ayoub Larabi, Pierre Verger, Fatima Gauna, Jean-Luc Cracowski & Jeremy Ward. (2022) Impact of Vaccine Hesitancy on Onset, Severity and Type of Self-reported Adverse Events: A French Cross-Sectional Survey. Drug Safety 45:10, pages 1049-1056.
Crossref
Julia W. Haas, Friederike L. Bender, Sarah Ballou, John M. Kelley, Marcel Wilhelm, Franklin G. Miller, Winfried Rief & Ted J. Kaptchuk. (2022) Frequency of Adverse Events in the Placebo Arms of COVID-19 Vaccine Trials. JAMA Network Open 5:1, pages e2143955.
Crossref
Martina Amanzio, Dimos D Mitsikostas, Fabio Giovannelli, Massimo Bartoli, Giuseppina Elena Cipriani & Walter A Brown. (2022) Adverse events of active and placebo groups in SARS-CoV-2 vaccine randomized trials: A systematic review. The Lancet Regional Health - Europe 12, pages 100253.
Crossref
Fabrizio Benedetti, Martina Amanzio, Fabio Giovannelli, Karen Craigs‐Brackhahn & Aziz Shaibani. (2021) Hypothalamic‐Pituitary‐Adrenal Activity in Adverse Events Reporting After Placebo Administration. Clinical Pharmacology & Therapeutics 110:5, pages 1349-1357.
Crossref
Dimos D. Mitsikostas, Konstantina Aravantinou-Fatorou, Christina Deligianni, Evrydiki Kravvariti, Eleni Korompoki, Maria Mylona, Pinelopi Vryttia, Georgia Papagiannopoulou, Eumorphia-Maria Delicha, Athanasios Dellis, Georgios Tsivgoulis, Meletios A. Dimopoulos, Martina Amanzio & Petros P. Sfikakis. (2021) Nocebo-Prone Behavior Associated with SARS-CoV-2 Vaccine Hesitancy in Healthcare Workers. Vaccines 9:10, pages 1179.
Crossref
Massimo Bartoli, Nicola Canessa, Giuseppina Elena Cipriani, Stefano F. Cappa & Martina Amanzio. (2021) The Role of Neuropsychological Factors in Perceived Threat of SARS-CoV-2 in Healthy Ageing. International Journal of Environmental Research and Public Health 18:11, pages 5847.
Crossref
ChaucerChiao-Hsiang Lin. (2021) Nocebo effects from COVID-19 and vaccination Hesitancy: The question of to be or not to be vaccinated. Taiwanese Journal of Psychiatry 35:4, pages 157.
Crossref
Dimos D. Mitsikostas, Konstantina Aravantinou-Fatorou, Christina Deligianni, Evrydiki KravvaritiM, Eleni Korompoki, Maria Mylona, Pinelopi Vryttia, Georgia Papagiannopoulou, Eumorphia-Maria Delicha, Athanasios Dellis, Georgios Tsivgoulis, Meletios A. Dimopoulos, Martina Amanzio & Petros Sfikakis. (2021) Nocebo-Prone Behavior Contributes to SARS-CoV-2 Vaccine Hesitancy in Healthcare Workers. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.